<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03217578</url>
  </required_header>
  <id_info>
    <org_study_id>SMA-NBS001</org_study_id>
    <nct_id>NCT03217578</nct_id>
  </id_info>
  <brief_title>Neonatal Spinal Muscular Atrophy (SMA) Screening</brief_title>
  <acronym>SMA</acronym>
  <official_title>Study on the Neonatal Screening of Spinal Muscular Atrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Medical University Chung-Ho Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Chinese Foundation of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taipei Institute of Pathology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaohsiung Medical University Chung-Ho Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parents or legal guardian of neonates who signed agreement will receive SMA screening test if
      their neonates are affected with SMA. The dried blood spots of routine newborn screening
      samples will be used to test if neonates have lost 2 copies of SMN1 gene. If neonates have
      positive SMA screening test, further confirmation with multiplex ligation-dependent probe
      amplification (MLPA) test and prospective motor function monitoring including physical and
      neurological examinations will be proved to make SMA confirmation. For any confirmed SMA
      patient, genetic counseling and standard of care will be proved.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of neonates with confirmed the deletion of 2 copies of SMN1 gene</measure>
    <time_frame>3 years</time_frame>
    <description>Neonates with positive SMA newborn screening will be confirmed by multiplex ligation-dependent probe amplification (MLPA) test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of neonates with confirmed SMA</measure>
    <time_frame>3 years</time_frame>
    <description>Neonates with confirmed the deletion of 2 copies of SMN1 gene by MLPA test will be followed till SMA symptoms appear.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250000</enrollment>
  <condition>Spinal Muscular Atrophy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SMA Newborn Screening</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Neonates whose parents agree to be tested.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Neonates born in Taiwan who receive regular newborn screening suggested by Ministry of
             Heath and Welfare.

          2. Parents or legal guardian agree to perform SMA newborn screening.

        Exclusion Criteria:

        Parents or legal guardian do not agree to perform SMA newborn screening.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yun-Hui Chou</last_name>
    <phone>+886972977320</phone>
    <email>wendychoucrn@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kaohsiung Medical University Chung-Ho Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yun-Hui Chou</last_name>
      <phone>+886972977320</phone>
      <email>wendychoucrn@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yuh-Jyh Jong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2017</study_first_submitted>
  <study_first_submitted_qc>July 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2017</study_first_posted>
  <last_update_submitted>November 8, 2017</last_update_submitted>
  <last_update_submitted_qc>November 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spinal Muscular Atrophy</keyword>
  <keyword>Newborn Screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy, Spinal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is not a plan to make IPD available</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

